Levothyroxine: Thyroid medication recalled across US due to low potency

Jump to contentThank you for registeringPlease refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged inAllNewsSportCultureLifestyleMajor Pharmaceuticals is voluntarily recalling a number of Levothyroxine Sodium Tablets due to subpotency, the US Food and Drug Administration (FDA) has said.According to the government agency's Enforcement Report, the recall was initiated on July 13 and affects pills distributed by Major Pharmaceuticals and Cardinal Health.The recalled products include: Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg), 100 Tablets; Levothyroxine Sodium Tablets, USP, 50 mcg (0.050 mg), 100 Tablets; Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg), 100 Tablets; Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 100 Tablets; Levothyroxine Sodium Tablets, USP, 112 mcg (0.0112 mg), 100 Tablets; Levothyroxine Sodium Tablets, USP, 125 mcg (0.0125 mg), 100 Tablets and Levothyroxine Sodium Tablets, USP, 150 mcg (0.0150 mg), 100 Tablets. In addition, Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg), 10 Tablets; Levothyroxine Sodium Tablets, USP, 50 mcg (0.050 mg), 10 Tablets; Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg), 10 Tablets; Levothyroxine Sodium Tablets, USP, 125 mcg (0.0125 mg), 10 Tablets and Levothyroxine Sodium Tablets, USP, 150 mcg (0.0150 mg), 10 Tablets are also being recalled. Levothyroxine is a drug used in the treatment of hypothyroidism, “a condition where the thyroid gland does not produce enough thyroid hormone”, according to Mayo Clinic. More bulletinsThank you for registeringPlease refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in

Raccontata daeu.usatoday.commedpagetoday.comeconomictimes.indiatimes.comindependent.co.uk